ShareValue scores for 002644.SHE: Valuation 42, Quality 48, Growth 33, Health 57.

002644.SHE
SZSE

Lanzhou Foci Pharmaceutical Co Ltd

CN¥8.04(+3.21%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 15%
Valuation
42
Fair Value
Price vs Value
Quality
48
Moderate
Business Strength
Growth
33
Weak
Revenue & Earnings
Health
57
Moderate
Financial Stability
Momentum
39
Bearish
Price Trend

Company Details

About

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional Chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; pre-packaged food; processing and selling of Chinese herbal medicine pieces; technology development, and professional and technical services; inspection and testing services; and production and sales of medical devices. The company exports its products. LanZhou Foci Pharmaceutical Co.,Ltd. was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd. Address: No. 2289 Huashan Road, Lanzhou, China, 730000

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026